✦ LIBER ✦

178 Paclitaxel by 96-hour continuous infusion in combination with cisplatin: Preliminary results of a phase II trial in patients with advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Georgiadis, M.S.; Schuler, B.S.; Kelley, M.J.; Johnson, B.E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biweekly gemcitabine in two hours infusi

✍ I. Chacon; I. Garcia-Carbonero; L. Lopez; J. Andrade; B. Martinez; M. Cruz-Mora 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

128 Preliminary results of a phase II st

✍ Pérol, M.; Souquet, P.J.; Riou, R.; Fournel, P.; Dussopt, C.; Vuillermoz, S.; Bo 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 290 KB

Phase II trial of a 3-hour infusion of p

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Phase II study of paclitaxel (Genaxol®)

✍ Chen, Chih-Hung; Chang, Wen-Cheng; Lin, Meng-Chin; Hsu, Jen-Wen; Chao, Tsu-Yi; T 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 117 KB

136 Single centre phase II trial of pacl

✍ Ranson, M.; Anderson, H.; Jayson, G.; Thatcher, N. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Phase II study of a one hour paclitaxel

✍ Evans, W.K; Earle, C.C; Stewart, D.J; Dahrouge, S; Tomiak, E; Goss, G; Logan, D; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 147 KB